Potentially, the increases in CD1c+ B cells and CD56bright NK cells we observed after diagnosis of CIS would have prognostic value if these cell frequencies increase proximal to the development of new demyelinating lesions. This evidence concerns the gene CD1C and in situ carcinoma.